255 related articles for article (PubMed ID: 31853743)
21. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
22. [Staphylococcal toxic shock syndrome should be considered in the event of diffuse erythema with fever and shock].
Dugourd PM; Dupont A; Hubiche T; Chiaverini C; Alkhalifa A; Roudiere L; Tristan A; Gustave CA; Del Giudice P
Ann Dermatol Venereol; 2019 Apr; 146(4):287-291. PubMed ID: 30691878
[TBL] [Abstract][Full Text] [Related]
23. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
24. On the pathogenesis of toxic shock syndrome.
Kass EH; Parsonnet J
Rev Infect Dis; 1987; 9 Suppl 5():S482-9. PubMed ID: 3317745
[TBL] [Abstract][Full Text] [Related]
25. [Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].
Dickgiesser N; Brombacher A; Wiest W
Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):104-6. PubMed ID: 3569835
[TBL] [Abstract][Full Text] [Related]
26. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
27. Staphylococcus aureus producing toxic shock syndrome toxin 1 (TSST-1) in clinical specimens and vaginal swabs in Mannheim, West Germany.
Dickgiesser N; Brombacher A
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):323-9. PubMed ID: 3314262
[TBL] [Abstract][Full Text] [Related]
28. Toxic shock syndrome and tampons.
Schuchat A; Broome CV
Epidemiol Rev; 1991; 13():99-112. PubMed ID: 1662639
[TBL] [Abstract][Full Text] [Related]
29. Complex ecological interactions of Staphylococcus aureus in tampons during menstruation.
Jacquemond I; Muggeo A; Lamblin G; Tristan A; Gillet Y; Bolze PA; Bes M; Gustave CA; Rasigade JP; Golfier F; Ferry T; Dubost A; Abrouk D; Barreto S; Prigent-Combaret C; Thioulouse J; Lina G; Muller D
Sci Rep; 2018 Jul; 8(1):9942. PubMed ID: 29967393
[TBL] [Abstract][Full Text] [Related]
30. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
Wong AC; Downs SA
J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
[TBL] [Abstract][Full Text] [Related]
31. [Cases of menstrual toxic shock syndrome in the Czech Republic in 1997-2011].
Petrás P; Machová I; Rysková L; Prásil P
Epidemiol Mikrobiol Imunol; 2011 Nov; 60(4):161-6. PubMed ID: 22324245
[TBL] [Abstract][Full Text] [Related]
32. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
Lee AC; Crass BA; Bergdoll MS
J Clin Microbiol; 1987 Jan; 25(1):87-90. PubMed ID: 3793877
[TBL] [Abstract][Full Text] [Related]
33. The toxic shock syndrome revisited.
Kass EH
Postgrad Med J; 1985; 61 Suppl 1():45-8. PubMed ID: 4059159
[TBL] [Abstract][Full Text] [Related]
34. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
Schlievert PM
J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303
[TBL] [Abstract][Full Text] [Related]
35. Magnesium and the pathogenesis of toxic shock syndrome.
Kass EH
Rev Infect Dis; 1989; 11 Suppl 1():S167-73; discussion S173-5. PubMed ID: 2928633
[TBL] [Abstract][Full Text] [Related]
36. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.
Rosten PM; Bartlett KH; Chow AW
J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927
[TBL] [Abstract][Full Text] [Related]
37. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
38. Targeted Proteomics Analysis of Staphylococcal Superantigenic Toxins in Menstrual Fluid from Women with Menstrual Toxic Shock Syndrome (mTSS).
Courçon M; Badiou C; Louwagie M; Etievant S; Jaquinod M; Lina G; Brun V
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548783
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Toxic Shock Syndrome-Associated
Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
[TBL] [Abstract][Full Text] [Related]
40. Propensity of tampons and barrier contraceptives to amplify Staphylococcus aureusToxic shock syndrome toxin-I.
Tierno PM; Hanna BA
Infect Dis Obstet Gynecol; 1994; 2(3):140-5. PubMed ID: 18475381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
